PROJECT SPOTLIGHTS

OUR MISSION

The Mass General Global Cardiovascular Health Program aims to advance cardiovascular health equity globally through deep investment in local partnerships to support cardiovascular clinical infrastructure, bidirectional training and education, transformative research, and focused advocacy.

Support the Mass General Global Cardiovascular Health Program

LEADERSHIP

OYERE ONUMA, MD, MSC
Director, MGH Global Cardiovascular Health

Dr. Onuma brings her extensive expertise and experience from the World Health Organization leading global cardiovascular prevention efforts to Mass General.

Biography
Harvard Catalyst Profile

MEMBERS

DOREEN DEFARIA YEH, MD
DOREEN DEFARIA YEH, MDGlobal Education and Clinical Innovation
Heart Disease in the Young: congenital, rheumatic and maternal cardiology
Biography
Harvard Catalyst Profile
DR. KEMAR BROWN
DR. KEMAR BROWNAdvanced Heart Failure
DR. WILLIAM HUCKER
DR. WILLIAM HUCKERElectrophysiology
DR. FANIA MELA
DR. FANIA MELAElectrophysiology
DR. SHANA OSHO
DR. SHANA OSHOCardiac Surgery
DR. LEON PTAZSEK
DR. LEON PTAZSEKElectrophysiology
DR. THOR SUNDT
DR. THOR SUNDTCardiac Surgery
DR. CARL TURISSINI
DR. CARL TURISSINICardiologist; Director of Cardiovascular Partnership, Hôpital Sacré Coeur in Milot Haiti

INTRODUCTION

Cardiovascular disease is the number one cause of death and disability worldwide. 75% of premature cardiovascular deaths occur in low- and middle- income countries (LMICs). Many countries bear a double burden of ischemic heart disease and strokes, as well as an ongoing burden of neglected cardiovascular diseases including rheumatic heart disease.  In high income countries, significant innovations in cardiovascular diagnosis, drug and device therapy have reduced cardiovascular deaths by over 50% in the last 5 decades. However, these evidence-based and highly effective strategies to prevent and control cardiovascular disease such as blood-pressure and cholesterol lowering medications, penicillin treatment for rheumatic heart disease, heart failure treatment, percutaneous interventions, and cardiac surgery, amongst others, are lacking in many LMICs. There is a need to bridge the gaps to improve patient outcomes.

RESPONDING TO A GLOBAL EPIDEMIC

The Mass General Hospital Global Cardiovascular Health Program is an institutional response to the global cardiovascular disease epidemic. It leverages the world-renowned clinic and research expertise of Mass General faculty in various disciplines and draws on the extensive global health architecture that already exists in the Mass General and Harvard ecosystem. This includes the Mass General Global Health Institute, Harvard Institute of Global Health, and the Division of Global Health Equity at Harvard Medical School.

The program was inaugurated in 2023 under the leadership of Dr. Oyere Onuma and has over 15 affiliated Cardiology and Cardiac Surgery faculty and fellows, working across the globe. The program supports an important portfolio of high-impact projects In high-need areas that are co-developed through priority setting with in-country local partners and governments. Our engagement philosophy is centered on providing catalytic and time-bound support to create programs with long term sustainability under local control.

In these projects, Mass General Global Cardiovascular Health Program provides support in the form of technical expertise, planning and initial resources to support implementation. We concurrently work with partners to build a research and education/training scaffold that extends the impact of our work and trains the next cadre of leaders in the field.

Our current roster of ongoing projects include:

  • Peripartum cardiomyopathy clinic in Haiti – Dr. Carl Turassini
  • Rheumatic Heart Disease screening and secondary prevention in Cabo Verde – Dr. Doreen DeFaria Yeh, Dr. Oyere Onuma
  • Pacemaker Implantation in Cabo Verde – Dr. DeFaria Yeh, Dr. Leon Ptaszek, Dr. Bill Hucker
  • STEMI system of care in Kenya – Dr. Njambi Mathenge

CASE STUDY: CARDIOVASCULAR HEALTH SERVICES IN CAPE VERDE

Cape Verde is an archipelago of 10 islands on the Northwest coast of Africa. Total population is just under 500,000, with a significant number of citizens in the diaspora in Europe and in the United States.

Cardiovascular disease is the leading cause of death in Cabo Verde, primarily strokes likely driven by hypertension. There are very basic cardiovascular services in the referral hospitals in Praia (Hospital Aghostino Neto) and Mindelo (Hospital Baptista de Sousa) and the system is dependent on limited numbers of evacuations to Portugal to address any advanced conditions. There are only 11 cardiologists total in Cabo Verde, 5 work in the public system and 6 in private practice.

Following a situational analysis visit in April 2023, the MGH Global Cardiovascular Health Program proposed a long-term and multi-pronged partnership with colleagues and government in Cabo Verde to improve access to and quality of cardiovascular disease care on the islands.

Key Milestones

ECHO lab in Praia

ECHO lab in Praia

  • Initial engagement in April 2023, collaboration with the Cape Verdean American Medical Society (CVAMS)
  • Visit to Hospital Aghostino Neto in Praia, as well as providing clinical services in San Antoa and Fogo
  • Primary local partner is Dr. Luis Dias, Head of Cardiology at HUAN, Praia
  • MGH GCVHP hosted Dr. Dias and colleagues, including the Honorable Minister of Health, Cabo Verde in October 2023 during the CVAMS annual meeting.
  • 04/2024: Initial screening for Rheumatic Heart Disease Program
  • 06/2024: Pacemaker implantation program with Boston Cardiac Foundation

How can we impact care and outcomes?

  • First local Pacemaker Implantation program in Cape Verde (currently 150 patients on waiting list)- ongoing
  • National Rheumatic Heart Disease Screening program in Cape Verde (RHD is still endemic on multiple islands) – ongoing
  • Comprehensive program to support the treatment of CV risk factors including high blood pressure, high cholesterol, and diabetes at primary healthcare level.
  • Research training and mentorship for local cardiologists in Cape Verde
  • Cohort study of CV risk factors and disease incidence in Cape Verde and diaspora populations in Boston
  • Improve facilities and equipment for diagnosis and treatment of heart disease
  • Decrease mortality and morbidity from cardiovascular disease in Cabo Verde.

Photos

CARDIOVASCULAR HEALTH IN HAITI

Dr. Carl Turissini has been traveling to and working in Haiti for the last 15 years, making over 20 visits to Hôpital Sacré Coeur (HSC) in Milot Haiti and building their cardiovascular infrastructure.   In 2011, he started this work the donation of a single echocardiogram machine to the hospital, and since then the cardiovascular referral program has grown tremendously to now is the largest in the country.  Due to Dr. Turissini’s incredibly hard and dedication, the cardiovascular center in Milot now has  echocardiology, stress testing, Holter monitoring, Advanced cardiac life support, pediatric cardiology, pacemaker implantation, peripartum cardiomyopathy clinic, pericardiocentesis and more.  HSC is now building a 4 bed coronary care unit—the only in the country.

Dr. Turissini helped to facilitate the training of an internist at CHU Martinique, so the cardiovascular clinic at HSC now has one of the only full-time cardiologists in the country.  MGH Sonographer Carlene McClanahan and MGB cardiologist Mike Mazzini, MD are close collaborators and photographed below.

Photos